Bucciardini, R;
Fragola, V;
Massella, M;
Polizzi, C;
Mirra, M;
Goodall, R;
Carey, D;
... Floridia, M; + view all
(2007)
Health related quality of life outcomes in HIV-Infected patients starting different combination regimens in a randomised multinational trial: the INITIO-QoL Substudy.
AIDS Research and Human Retroviruses
, 23
(10)
pp. 1215-1222.
10.1089/aid.2007.0067.
Preview |
Text
Bucciardini et al 2007 Health related quality of life outcomes in HIV-Infected patients starting different combination regimens in a randomised multinational trial - the INITIO-QoL Substudy.pdf Download (284kB) | Preview |
Abstract
The health-related quality of life (HRQoL) outcomes in HIV-infected, treatment-naive patients starting different HAART regimens in a 3-year, randomized, multinational trial were compared. HRQoL was measured in a subgroup of patients enrolled in the INITIO study (153/911), using a modified version of the MOS-HIV questionnaire. The regimens compared in the INITIO trial were composed by two NRTIs (didanosine + stavudine) plus either an NNRTI (efavirenz) or a PI (nelfinavir), or both (efavirenz + nelfinavir). Primary HRQoL outcomes were Physical and Mental Health Summary scores (PHS and MHS, respectively). During follow-up, an increase of PHS score was observed in all treatment arms. The MHS score remained substantially unchanged with the four-drug combination and showed with both NNRTI- and PI-based three-drug regimens a marked trend toward improvement, which became statistically significant when a multiple imputation method was used to adjust for missing data. Overall, starting all the combination regimens compared in the INITIO study was associated with a maintained or slightly improved HRQOL status, consistently with the positive immunological and virological changes observed in the main study. The observed differences in the MHS indicate a possible HRQoL benefit associated to the use of three-drug, two-class regimens and no additional benefit for the use of four-drug, three-class regimens, confirming that three-drug, two-class regimens that include two NRTIs plus either an NNRTI or a PI should be preferred as initial treatment of HIV infection.
| Type: | Article |
|---|---|
| Title: | Health related quality of life outcomes in HIV-Infected patients starting different combination regimens in a randomised multinational trial: the INITIO-QoL Substudy |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1089/aid.2007.0067 |
| Publisher version: | http://dx.doi.org/10.1089/aid.2007.0067 |
| Language: | English |
| Additional information: | Copyright © Mary Ann Liebert, Inc. Final publication is available from Mary Ann Liebert, Inc., publishers: http://dx.doi.org/10.1089/aid.2007.0067. |
| Keywords: | HIV-infection, health-related quality of life, untreated patients, antiretroviral therapy |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL |
| URI: | https://discovery-pp.ucl.ac.uk/id/eprint/1489791 |
Archive Staff Only
 |
View Item |
